INO-9112

N/A

Report date: 2024/09/26 15:34:04

Base Information

Drug NameINO-9112
Drug Alias NameINO-9112
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsCoronavirus InfectionsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeTaiwan +[8
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus InfectionsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A